| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
|
Chest
|
2012
|
5.29
|
|
2
|
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
|
Chest
|
2012
|
5.27
|
|
3
|
Risk factors for venous thromboembolism.
|
Circulation
|
2003
|
4.64
|
|
4
|
Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta-analysis.
|
Ann Intern Med
|
2015
|
3.41
|
|
5
|
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
|
Ann Intern Med
|
2015
|
2.63
|
|
6
|
Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective.
|
Circulation
|
2009
|
2.60
|
|
7
|
Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
|
Chest
|
2012
|
2.55
|
|
8
|
A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
2.53
|
|
9
|
Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
|
Chest
|
2012
|
2.50
|
|
10
|
Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.
|
Chest
|
2007
|
2.32
|
|
11
|
Predicting deep venous thrombosis in pregnancy: out in "LEFt" field?
|
Ann Intern Med
|
2009
|
2.26
|
|
12
|
A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study).
|
Am J Cardiol
|
2004
|
2.10
|
|
13
|
Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial.
|
Ann Intern Med
|
2013
|
2.09
|
|
14
|
Incidence and hospital death rates associated with heart failure: a community-wide perspective.
|
Am J Med
|
2005
|
1.90
|
|
15
|
Long-term survival after heart failure: a contemporary population-based perspective.
|
Arch Intern Med
|
2007
|
1.81
|
|
16
|
Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials.
|
Crit Care Med
|
2013
|
1.79
|
|
17
|
Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.
|
Chest
|
2010
|
1.67
|
|
18
|
Venous thromboembolism in patients with symptomatic atherosclerosis.
|
Thromb Haemost
|
2011
|
1.52
|
|
19
|
Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
|
Chest
|
2012
|
1.46
|
|
20
|
Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes: findings from a Global Registry of Acute Coronary Events.
|
Circulation
|
2005
|
1.42
|
|
21
|
30-year trends in heart failure in patients hospitalized with acute myocardial infarction.
|
Am J Cardiol
|
2011
|
1.39
|
|
22
|
Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
|
Eur Heart J
|
2005
|
1.39
|
|
23
|
Trends in prehospital delay in patients with acute myocardial infarction (from the Worcester Heart Attack Study).
|
Am J Cardiol
|
2008
|
1.36
|
|
24
|
Twenty-year trends in the incidence of stroke complicating acute myocardial infarction: Worcester Heart Attack Study.
|
Arch Intern Med
|
2008
|
1.32
|
|
25
|
Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
|
Chest
|
2012
|
1.31
|
|
26
|
Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality.
|
Am J Cardiol
|
2005
|
1.19
|
|
27
|
Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]).
|
Am J Cardiol
|
2009
|
1.18
|
|
28
|
Changing trends in the long-term prognosis of patients with acute myocardial infarction: a population-based perspective.
|
Am Heart J
|
2006
|
1.14
|
|
29
|
Formatting modifications in GRADE evidence profiles improved guideline panelists comprehension and accessibility to information. A randomized trial.
|
J Clin Epidemiol
|
2012
|
1.11
|
|
30
|
Trends in mortality attributed to heart failure in Worcester, Massachusetts, 1992 to 2001.
|
Am J Cardiol
|
2005
|
1.10
|
|
31
|
Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions.
|
Am J Med
|
2010
|
1.07
|
|
32
|
Cognitive impairment and self-care in heart failure.
|
Clin Epidemiol
|
2013
|
1.05
|
|
33
|
Clinical features, treatment practices, and hospital and long-term outcomes of older patients hospitalized with decompensated heart failure: The Worcester Heart Failure Study.
|
J Am Geriatr Soc
|
2009
|
1.05
|
|
34
|
Use of disease-modifying therapies in patients hospitalized with heart failure: a population-based perspective.
|
Am J Med
|
2007
|
1.03
|
|
35
|
Epidemiology of decompensated heart failure in a single community in the northeastern United States.
|
Am J Cardiol
|
2009
|
1.02
|
|
36
|
Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry.
|
Coron Artery Dis
|
2010
|
1.00
|
|
37
|
Long-term trends in short-term outcomes in acute myocardial infarction.
|
Am J Med
|
2011
|
0.99
|
|
38
|
Contemporary trends in evidence-based treatment for acute myocardial infarction.
|
Am J Med
|
2010
|
0.97
|
|
39
|
Anatomic distribution of deep vein thrombosis in pregnancy.
|
CMAJ
|
2010
|
0.96
|
|
40
|
Delays in seeking medical care in hospitalized patients with decompensated heart failure.
|
Am J Med
|
2008
|
0.95
|
|
41
|
Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective.
|
Arch Intern Med
|
2007
|
0.95
|
|
42
|
Age and sex differences and 20-year trends (1986 to 2005) in prehospital delay in patients hospitalized with acute myocardial infarction.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
0.94
|
|
43
|
Development of a novel, multilayered presentation format for clinical practice guidelines.
|
Chest
|
2015
|
0.93
|
|
44
|
Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction.
|
Am J Cardiol
|
2011
|
0.92
|
|
45
|
Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes.
|
Am Heart J
|
2010
|
0.90
|
|
46
|
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes.
|
Am Heart J
|
2002
|
0.87
|
|
47
|
Symptom presentation in patients hospitalized with acute heart failure.
|
Clin Cardiol
|
2010
|
0.87
|
|
48
|
Delayed hospital presentation in acute decompensated heart failure: clinical and patient reported factors.
|
Heart Lung
|
2013
|
0.86
|
|
49
|
Trends in the medical management of patients with heart failure.
|
J Clin Med Res
|
2013
|
0.86
|
|
50
|
Use of nonpharmacologic treatment approaches in patients with heart failure.
|
Int J Cardiol
|
2006
|
0.86
|
|
51
|
Thirty-year trends (1975-2005) in the magnitude and hospital death rates associated with complete heart block in patients with acute myocardial infarction: a population-based perspective.
|
Am Heart J
|
2008
|
0.85
|
|
52
|
Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial.
|
Implement Sci
|
2013
|
0.84
|
|
53
|
Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]).
|
Am J Cardiol
|
2008
|
0.84
|
|
54
|
Retracted
Long-term trends (1986-2003) in the use of coronary reperfusion strategies in patients hospitalized with acute myocardial infarction in central Massachusetts.
|
Int J Cardiol
|
2008
|
0.83
|
|
55
|
Venous thromboembolism in patients with chronic obstructive pulmonary disease.
|
Am J Med
|
2012
|
0.83
|
|
56
|
Barriers and potential solutions toward optimal prophylaxis against deep vein thrombosis for hospitalized medical patients: a survey of healthcare professionals.
|
J Hosp Med
|
2011
|
0.82
|
|
57
|
A community-wide perspective into changing trends in the utilization of diagnostic and interventional procedures in patients hospitalized with acute myocardial infarction.
|
Am Heart J
|
2007
|
0.82
|
|
58
|
Venous thromboembolism in patients with diabetes mellitus.
|
Am J Med
|
2012
|
0.82
|
|
59
|
Venous thromboembolism in heart failure: preventable deaths during and after hospitalization.
|
Am J Med
|
2011
|
0.82
|
|
60
|
Culprit vessel only vs immediate complete revascularization in patients with acute ST-segment elevation myocardial infarction: systematic review and meta-analysis.
|
Clin Cardiol
|
2014
|
0.82
|
|
61
|
Venous thromboembolism in patients with reduced estimated GFR: a population-based perspective.
|
Am J Kidney Dis
|
2011
|
0.81
|
|
62
|
Changes over time in the use of aspirin in patients hospitalized with acute myocardial infarction (1975 to 1997): a population-based perspective.
|
Am Heart J
|
2002
|
0.81
|
|
63
|
Circadian variations in acute myocardial infarction: patients or health care delivery?
|
J Am Coll Cardiol
|
2003
|
0.81
|
|
64
|
Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes.
|
Am Heart J
|
2009
|
0.81
|
|
65
|
Long-term trends in the use of coronary reperfusion strategies in acute myocardial infarction: a community-wide perspective.
|
J Thromb Thrombolysis
|
2007
|
0.80
|
|
66
|
Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor.
|
J Thromb Thrombolysis
|
2003
|
0.80
|
|
67
|
Thirty-year trends (1975-2005) in the magnitude, patient characteristics, and hospital outcomes of patients with acute myocardial infarction complicated by ventricular fibrillation.
|
Am J Cardiol
|
2008
|
0.80
|
|
68
|
Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation.
|
Can J Cardiol
|
2012
|
0.79
|
|
69
|
Multidecade-long trends (1986-2005) in the utilization of coronary reperfusion and revascularization treatment strategies in patients hospitalized with acute myocardial infarction: a community-wide perspective.
|
Coron Artery Dis
|
2009
|
0.79
|
|
70
|
Decompensated heart failure in the setting of kidney dysfunction: a community-wide perspective.
|
Nephron Clin Pract
|
2007
|
0.79
|
|
71
|
Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition.
|
Am Heart J
|
2002
|
0.78
|
|
72
|
A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era...
|
Am Heart J
|
2005
|
0.78
|
|
73
|
Survival after hospital discharge for ST-segment elevation and non-ST-segment elevation acute myocardial infarction: a population-based study.
|
Clin Epidemiol
|
2013
|
0.78
|
|
74
|
Venous thromboembolism in patients with prior stroke.
|
Clin Appl Thromb Hemost
|
2013
|
0.77
|
|
75
|
Changing trends (1986-2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: a community-based perspective.
|
Int J Cardiol
|
2008
|
0.77
|
|
76
|
Thromboepidemiology: identifying patients with heritable risk for thrombin-mediated thromboembolic events.
|
Am Heart J
|
2005
|
0.77
|
|
77
|
Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review.
|
J Thromb Thrombolysis
|
2013
|
0.77
|
|
78
|
Management and outcomes of non-ST elevation acute coronary syndromes in relation to previous use of antianginal therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).
|
Am J Cardiol
|
2013
|
0.77
|
|
79
|
Therapies for acute heart failure in patients with reduced kidney function: a community-based perspective.
|
Am J Kidney Dis
|
2008
|
0.77
|
|
80
|
Temporal patterns of lipid testing and statin therapy in acute coronary syndrome patients (from the Canadian GRACE Experience).
|
Am J Cardiol
|
2012
|
0.77
|
|
81
|
Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events).
|
Am J Cardiol
|
2005
|
0.76
|
|
82
|
Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging.
|
CMAJ
|
2013
|
0.76
|
|
83
|
Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.
|
J Thromb Thrombolysis
|
2002
|
0.76
|
|
84
|
Hospitalization for hemorrhage among warfarin recipients prescribed amiodarone.
|
Am J Cardiol
|
2013
|
0.76
|
|
85
|
Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort.
|
Anesthesiology
|
2016
|
0.76
|
|
86
|
ACP journal club. Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events.
|
Ann Intern Med
|
2015
|
0.75
|
|
87
|
Response.
|
Chest
|
2013
|
0.75
|
|
88
|
Recurrence after unprovoked venous thromboembolism.
|
BMJ
|
2011
|
0.75
|
|
89
|
When guidelines collide...
|
Am Heart J
|
2004
|
0.75
|
|
90
|
Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitor.
|
J Thromb Thrombolysis
|
2004
|
0.75
|
|
91
|
Major bleeding after PCI. Where is our crystal ball?
|
Eur Heart J
|
2007
|
0.75
|
|
92
|
Use of heparins in Non-ST-elevation acute coronary syndromes.
|
Am J Med
|
2007
|
0.75
|
|
93
|
Incidence of deep vein thrombosis in erysipelas or cellulitis of the lower extremities.
|
Int J Dermatol
|
2012
|
0.75
|
|
94
|
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist.
|
Thromb Haemost
|
2004
|
0.75
|